RxDoctor Payments Data

Ravi Patel, PA

Physician Assistant · Peterborough, NHNPI 1457808941

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 31.1% of the total. Reporting peaked in 2023 at $817 and has fallen 98.0% since, to $17 in 2025. Among physician assistant clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,848in general payments, 2019–2025

Across 80 payments — averaging $23.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$574
  • Nevro Corp.$562
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$170
  • Scilex Pharmaceuticals Inc.$129
  • Abbott$83
  • Painteq LLC$79
  • plus $250 from 9 others

What the payments were for

  • Food & beverage$1,848100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,848 in reported general payments places this provider in the 90th percentile of 782 physician assistant providers in New Hampshire.

See all physician assistant providers in New Hampshire

Medicare billing

Part B allowed, 2024
$15,469
Medicare patients
191
Services billed
279

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RelistorMethylnaltrexone Bromide16$36,625
Buprenorphine25$7,624
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen266$6,325
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen96$2,638
Pregabalin68$1,805
Morphine Sulfate ErMorphine Sulfate54$1,139
Gabapentin108$1,018
Cyclobenzaprine Hcl91$965
Diclofenac Sodium14$759
Acetaminophen-CodeineAcetaminophen With Codeine27$738
Tramadol Hcl83$541
Oxycodone Hcl22$495
Baclofen35$476
Tizanidine Hcl62$376
Ibuprofen34$177

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$170$36,62516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 782 physician assistant providers in New Hampshire.

Other physician assistant in Peterborough

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →